SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $30,000 | – | 114,026 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 23,634,349 | $149,133,000 | 99.87% |
Perceptive Advisors | 4,762,472 | $30,052,000 | 1.24% |
QVT Financial LP | 1,750,285 | $11,044,000 | 0.75% |
NBW CAPITAL LLC | 404,721 | $2,554,000 | 0.45% |
Tekla Capital Management LLC | 489,750 | $3,090,000 | 0.34% |
MILES CAPITAL, INC. | 57,904 | $365,000 | 0.21% |
FULLER & THALER ASSET MANAGEMENT, INC. | 435,200 | $2,746,000 | 0.16% |
Old West Investment Management, LLC | 49,136 | $310,000 | 0.15% |
Integre Asset Management, LLC | 84,420 | $533,000 | 0.14% |
SABBY MANAGEMENT, LLC | 250,952 | $1,584,000 | 0.10% |